Estimate Recalculated Nov 7, 2024 04:53PM EST
Rafael Amado has an estimated net worth of $4.26 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Adaptimmune Therapeutics PLC, Zai Lab Ltd, and Poseida Therapeutics, Inc..
Rafael Amado's CIK is 0001662119
2023 was Rafael Amado's most active year for acquiring shares with 6 total transactions. Rafael Amado's most active month to acquire stocks was the month of December. 2022 was Rafael Amado's most active year for disposing of shares, totalling 7 transactions. Rafael Amado's most active month to dispose stocks was the month of September. 2024 saw Rafael Amado paying a total of $85,716.90 for 250,624 shares, this is the most they've acquired in one year. In 2020 Rafael Amado cashed out on 26,290 shares for a total of $1,006,176.22, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!